Cleveland BioLabs, Inc.’s (CBLI) MACD indicator has entered into bearish territory with a reading of -0.0324. The Zacks #4 Rank (“Sell”) stock decreased slightly to $6.12 in morning trade. The Zacks Consensus Estimate for the year ending 2010 has worsened by 18 cents over the past month to a loss of 63 cents per share.
 
CLEVELAND BIOLB (CBLI): Free Stock Analysis Report
 
Zacks Investment Research